Skip to content

Insider · CIK 0001304340

Marc L Panoff

officer

Files at LBRX (LB PHARMACEUTICALS INC). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-3,944--0Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AGrant or award
Employee Stock Option (Right to Buy)derivative
+3,944--3,944Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-896--0Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AGrant or award
Employee Stock Option (Right to Buy)derivative
+896--896Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-1,255--0Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AGrant or award
Employee Stock Option (Right to Buy)derivative
+1,255--1,255Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-14,343--0Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AGrant or award
Employee Stock Option (Right to Buy)derivative
+14,343--14,343Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-7,171--0Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AGrant or award
Employee Stock Option (Right to Buy)derivative
+7,171--7,171Sep 29, 2025
Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AGrant or award
Employee Stock Option (Right to Buy)derivative
+90,525$0.00$090,525Sep 29, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Marc L Panoff: insider trades and track record | InsiderTell